| | Research Strategies for Safety Evaluation of Nanomaterials, Part |
| | 0,35 | | MB | IV: Risk Assessment of Nanoparticles |
| | 9 | | stron |
| | 2583 | | ID | ENVIRON International Corporation |
| | 2006 | | rok |
| | Nanoparticles are small-scale substances (<100 nm) with unique properties and, thus, complex |
| | exposure and health risk implications. |
| | This symposium review summarizes recent findings in exposure and toxicity of nanoparticles and |
| | their application for assessing human health risks. Characterization of airborne particles indicates |
| | that exposures will depend on particle behavior (e.g., disperse or aggregate) and that accurate, |
| | portable, and costeffective measurement techniques are essential for understanding exposure. |
| | Under many conditions, dermal penetration of nanoparticles may be limited for consumer products |
| | such as sunscreens, although additional studies are needed on potential photooxidation products, |
| | experimental methods, and the effect of skin condition on penetration. Carbon nanotubes |
| | apparently have greater pulmonary toxicity (inflammation, granuloma) in mice than fine-scale |
| | carbon graphite, and their metal content may affect toxicity. |
| | Studies on TiO2 and quartz illustrate the complex relationship between toxicity and particle |
| | characteristics, including surface coatings, which make generalizations (e.g., smaller particles are |
| | always more toxic) incorrect for some substances. These recent toxicity and exposure data, |
| | combined with therapeutic and other related literature, are beginning to shape risk assessments that |
| | will be used to regulate the use of nanomaterials in consumer products. |
| | Key Words: nanotechnology; nanoparticles; risk assessment; exposure assessment. |